183 related articles for article (PubMed ID: 32983972)
21. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women.
Ushijima K; Yahata H; Yoshikawa H; Konishi I; Yasugi T; Saito T; Nakanishi T; Sasaki H; Saji F; Iwasaka T; Hatae M; Kodama S; Saito T; Terakawa N; Yaegashi N; Hiura M; Sakamoto A; Tsuda H; Fukunaga M; Kamura T
J Clin Oncol; 2007 Jul; 25(19):2798-803. PubMed ID: 17602085
[TBL] [Abstract][Full Text] [Related]
22. Endometrioid carcinomas with sex cord-like formations and hyalinization: spontaneous pregnancy after conservative treatment.
Gama Q; Luo S; Wu P; Wang L; Liu S; Zhang H; Sun L; Wang Y; Yu M; Chen X; Shan W; Luo X
BMC Pregnancy Childbirth; 2024 Jan; 24(1):30. PubMed ID: 38178060
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors of oncologic outcomes after fertility-preservative management with progestin in early-stage of endometrial cancer.
Roh HJ; Yoon HJ; Jeong DH; Lee TH; Kwon BS; Suh DS; Kim KH
J Res Med Sci; 2021; 26():48. PubMed ID: 34484380
[TBL] [Abstract][Full Text] [Related]
24. Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer.
Park JY; Seong SJ; Kim TJ; Kim JW; Kim SM; Bae DS; Nam JH
Obstet Gynecol; 2013 Jan; 121(1):136-42. PubMed ID: 23262938
[TBL] [Abstract][Full Text] [Related]
25. Sparing Is Caring: Hormonal Retreatment in Women with Recurrent Endometrial Cancer after Fertility Preservation Management-A Single Centre Retrospective Study.
Pino I; Di Giminiani M; Radice D; Vidal Urbinati AM; Iacobone AD; Guerrieri ME; Preti EP; Martella S; Franchi D
Healthcare (Basel); 2023 Apr; 11(7):. PubMed ID: 37046985
[TBL] [Abstract][Full Text] [Related]
26. Fertility-Sparing Treatment for Endometrial Cancer: Oncological and Obstetric Outcomes in Combined Therapies with Levonorgestrel Intrauterine Device.
Pino I; Iacobone AD; Vidal Urbinati AM; Di Giminiani M; Radice D; Guerrieri ME; Preti EP; Martella S; Franchi D
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565299
[TBL] [Abstract][Full Text] [Related]
27. Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women.
Minig L; Franchi D; Boveri S; Casadio C; Bocciolone L; Sideri M
Ann Oncol; 2011 Mar; 22(3):643-649. PubMed ID: 20876910
[TBL] [Abstract][Full Text] [Related]
28. Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.
Simpson AN; Feigenberg T; Clarke BA; Gien LT; Ismiil N; Laframboise S; Massey C; Ferguson SE
Gynecol Oncol; 2014 May; 133(2):229-33. PubMed ID: 24561246
[TBL] [Abstract][Full Text] [Related]
29. Optimal duration of fertility-sparing hormonal treatment for early-stage endometrioid endometrial cancer.
Shim SH; Chae SH; So KA; Lee SJ; Lee JY; Kim TJ; Han ES; Kang SB
Gynecol Oncol; 2021 Jun; 161(3):810-816. PubMed ID: 33875233
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study.
Leone Roberti Maggiore U; Martinelli F; Dondi G; Bogani G; Chiappa V; Evangelista MT; Liberale V; Ditto A; Ferrero S; Raspagliesi F
J Gynecol Oncol; 2019 Jul; 30(4):e57. PubMed ID: 31074240
[TBL] [Abstract][Full Text] [Related]
31. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
32. Conservative management of grade 2 stage IA endometrial carcinoma and literature review.
Shan W; Wu P; Yang B; Zhang H; Sun L; Lv Q; Luo X; Cheng Y; Zhu Q; Chen X
J Obstet Gynaecol Res; 2021 Mar; 47(3):984-991. PubMed ID: 33403812
[TBL] [Abstract][Full Text] [Related]
33. Six months response rate of combined oral medroxyprogesterone/levonorgestrel-intrauterine system for early-stage endometrial cancer in young women: a Korean Gynecologic-Oncology Group Study.
Kim MK; Seong SJ; Kang SB; Bae DS; Kim JW; Nam JH; Lim MC; Lee TS; Kim S; Paek J
J Gynecol Oncol; 2019 Mar; 30(2):e47. PubMed ID: 30740964
[TBL] [Abstract][Full Text] [Related]
34. Measurement of endometrial thickness by transvaginal ultrasonography to predict pathological response to medroxyprogesterone acetate in patients with grade 1 endometrioid adenocarcinoma.
Sato M; Arimoto T; Kawana K; Miyamoto Y; Ikeda Y; Tomio K; Tanikawa M; Sone K; Mori-Uchino M; Tsuruga T; Nagasaka K; Adachi K; Matsumoto Y; Oda K; Osuga Y; Fujii T
Mol Clin Oncol; 2016 Apr; 4(4):492-496. PubMed ID: 27073648
[TBL] [Abstract][Full Text] [Related]
35. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy.
De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni GL; Mangili G; Colombo G; Candiani M
J Minim Invasive Gynecol; 2015; 22(7):1178-82. PubMed ID: 26092080
[TBL] [Abstract][Full Text] [Related]
36. Management of Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Patients After Primary Fertility-Sparing Therapy.
Chen J; Cao D; Yang J; Yu M; Zhou H; Cheng N; Wang J; Zhang Y; Peng P; Shen K
Front Oncol; 2021; 11():738370. PubMed ID: 34568074
[TBL] [Abstract][Full Text] [Related]
37. Fertility-sparing surgeries without adjuvant therapy through term pregnancies in a patient with low-grade endometrial stromal sarcoma: A case report.
Gu YZ; Duan NY; Cheng HX; Xu LQ; Meng JL
World J Clin Cases; 2021 Feb; 9(4):983-991. PubMed ID: 33585648
[TBL] [Abstract][Full Text] [Related]
38. Fertility-preserving treatment in young patients with endometrial adenocarcinoma.
Wang CB; Wang CJ; Huang HJ; Hsueh S; Chou HH; Soong YK; Lai CH
Cancer; 2002 Apr; 94(8):2192-8. PubMed ID: 12001117
[TBL] [Abstract][Full Text] [Related]
39. Oncologic and pregnancy outcomes after fertility-sparing surgery for stage I, low-grade endometrioid ovarian cancer.
Swift BE; Covens A; Mintsopoulos V; Parra-Herran C; Bernardini MQ; Nofech-Mozes S; Hogen L
Int J Gynecol Cancer; 2022 Jun; ():. PubMed ID: 35768155
[TBL] [Abstract][Full Text] [Related]
40. Hysteroscopic Curettage Followed by Megestrol Acetate Plus Metformin as a Fertility-Sparing Treatment for Women with Atypical Endometrial Hyperplasia or Well-Differentiated Endometrioid Endometrial Carcinoma.
Jing CY; Li SN; Shan BE; Zhang W; Tian WJ; Ren YL; Wang HY
Clin Med Insights Oncol; 2022; 16():11795549221110522. PubMed ID: 35875417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
